Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Cipla
Boehringer Ingelheim
Julphar
Fuji
Merck
UBS
Chinese Patent Office
Medtronic

Generated: December 18, 2018

DrugPatentWatch Database Preview

Organon Usa Inc Company Profile

« Back to Dashboard

Summary for Organon Usa Inc
International Patents:146
US Patents:7
Tradenames:32
Ingredients:26
NDAs:30

Drugs and US Patents for Organon Usa Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc ZEMURON rocuronium bromide INJECTABLE;INJECTION 020214-001 Mar 17, 1994 DISCN Yes No ➤ Sign Up ➤ Sign Up
Organon Usa Inc PREGNYL gonadotropin, chorionic INJECTABLE;INJECTION 017692-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Sign Up ➤ Sign Up
Organon Usa Inc HUMEGON menotropins (fsh;lh) INJECTABLE;INJECTION 020328-002 Sep 1, 1994 DISCN No No ➤ Sign Up ➤ Sign Up
Organon Usa Inc LIQUAEMIN SODIUM heparin sodium INJECTABLE;INJECTION 000552-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Organon Usa Inc FOLLISTIM AQ follitropin alfa/beta INJECTABLE;SUBCUTANEOUS 021211-002 Mar 23, 2004 RX Yes Yes 5,929,028 ➤ Sign Up Y ➤ Sign Up
Organon Usa Inc FOLLISTIM AQ follitropin alfa/beta INJECTABLE;SUBCUTANEOUS 021211-004 Feb 11, 2005 RX Yes Yes 7,446,090 ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Organon Usa Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc REMERON mirtazapine TABLET;ORAL 020415-002 Jun 14, 1996 5,977,099 ➤ Sign Up
Organon Usa Inc FOLLISTIM AQ follitropin alfa/beta INJECTABLE;SUBCUTANEOUS 021211-001 Mar 23, 2004 5,767,251 ➤ Sign Up
Organon Usa Inc FOLLISTIM follitropin alfa/beta INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 020582-001 Sep 29, 1997 5,767,251 ➤ Sign Up
Organon Usa Inc REMERON SOLTAB mirtazapine TABLET, ORALLY DISINTEGRATING;ORAL 021208-001 Jan 12, 2001 5,977,099 ➤ Sign Up
Organon Usa Inc FOLLISTIM AQ follitropin alfa/beta INJECTABLE;SUBCUTANEOUS 021211-001 Mar 23, 2004 4,589,402 ➤ Sign Up
Organon Usa Inc FOLLISTIM AQ follitropin alfa/beta INJECTABLE;SUBCUTANEOUS 021211-001 Mar 23, 2004 5,929,028 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for ORGANON USA INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 250 mcg/0.5 mL, 1 mL PFS ➤ Subscribe 2012-03-30

Supplementary Protection Certificates for Organon Usa Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2010 00022 Denmark ➤ Sign Up
C0024 France ➤ Sign Up PRODUCT NAME: CORIFOLLITROPINE ALPHA; REGISTRATION NO/DATE: EU/1/09/609/001 20100125
6/2010 Austria ➤ Sign Up PRODUCT NAME: CORIFOLLITROPIN ALFA
/1999 Austria ➤ Sign Up PRODUCT NAME: ETONOGESTREL; NAT. REGISTRATION NO/DATE: 1-22964 19990330; FIRST REGISTRATION: NL 21168 19980825
00C/030 Belgium ➤ Sign Up PRODUCT NAME: GANIRELIX; REGISTRATION NO/DATE: EU/1/00/130/001 20000518
00016 Netherlands ➤ Sign Up PRODUCT NAME: GANIRELIX, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; NATL REGISTRATION NO/DATE: EU/1/00/130/001-002 20000517
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Cerilliant
Farmers Insurance
Accenture
Cipla
Federal Trade Commission
Daiichi Sankyo
Baxter
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.